SCHEMBL30248459

SCHEMBL30248459

Fc1cc2ccccc2nn1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 4/20 0.52
▸ MAPT P10636 3/20 0.52
▸ HPGD P15428 3/20 0.52
▸ GLA P06280 2/20 0.52
▸ ACHE P22303 1/20 0.52
▸ KDM4E B2RXH2 3/20 0.52
▸ NQO2 P16083 2/20 0.44
▸ GPR3 P46089 1/20 0.42
▸ CYP1A2 P05177 2/20 0.40
▸ MBNL1 Q9NR56 1/20 0.40
▸ PDPK1 O15530 1/20 0.39
▸ GAA P10253 2/20 0.39
▸ HTR3A P46098 1/20 0.39
▸ TDP1 Q9NUW8 1/20 0.39
▸ STAT3 P40763 1/20 0.39
▸ KMT2A Q03164 3/20 0.38
▸ NPC1 O15118 2/20 0.38
▸ POLB P06746 2/20 0.38
▸ LMNA P02545 1/20 0.38
▸ PTBP1 P26599 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11173734 1.00 ALDH1A1 (0.52) ALDH1A1MAPTHPGDGLAACHE
Hydrochloric Acid SCHEMBL21979894 0.98 ALDH1A1 (0.50) ALDH1A1MAPTHPGDGLAACHE
SCHEMBL31115164 0.77 ALDH1A1 (0.55) ALDH1A1MAPTHPGDGLAACHE
SCHEMBL5483645 0.77 ALDH1A1 (0.55) ALDH1A1MAPTHPGDGLAACHE
SCHEMBL11389056 0.76 KDM4E (0.44) ALDH1A1MAPTHPGDGLAACHE
SCHEMBL11400875 0.76 KDM4E (0.44) ALDH1A1MAPTHPGDGLAACHE
SCHEMBL3071109 0.73 ALDH1A1 (0.50) ALDH1A1MAPTHPGDGLAACHE
SCHEMBL2014207 0.73 ALDH1A1 (0.50) ALDH1A1MAPTHPGDGLAACHE
SCHEMBL276035 0.73 ALDH1A1 (0.50) ALDH1A1MAPTHPGDGLAACHE
SCHEMBL241706 0.73 ALDH1A1 (0.50) ALDH1A1MAPTHPGDGLAACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230058189-A1 QUINOLIN-4-ONE AND 4(1H)-CINNOLINONE COMPOUNDS AND METHODS OF USING SAME Frequency Therapeutics, Inc. (US) 2023-02-23 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230058189-A1 QUINOLIN-4-ONE AND 4(1H)-CINNOLINONE COMPOUNDS AND METHODS OF USING SAME DCX, NES, MCL1 ALDH1A1 102/4885MAPT 4767/4885HPGD 218/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback